Relationships between serum iron and liver diseases in nutrition intervention trials: A nested case-control study.

[1]  L. D’Antiga,et al.  Breakthroughs and challenges in the management of pediatric viral hepatitis , 2021, World journal of gastroenterology.

[2]  Zhengming Chen,et al.  Alcohol drinking and risks of total and site‐specific cancers in China: A 10‐year prospective study of 0.5 million adults , 2021, International journal of cancer.

[3]  C. Abnet,et al.  Independent and Joint Associations between Serum Calcium, 25-Hydroxy Vitamin D, and the Risk of Primary Liver Cancer: A Prospective Nested Case–Control Study , 2020, Cancer Epidemiology, Biomarkers & Prevention.

[4]  Yufeng Hu,et al.  Elevated serum iron level is a predictor of prognosis in ICU patients with acute kidney injury , 2020, BMC Nephrology.

[5]  S. Larsson,et al.  Iron Status and Cancer Risk in UK Biobank: A Two-Sample Mendelian Randomization Study , 2020, Nutrients.

[6]  D. Swinkels,et al.  The multifaceted role of iron in renal health and disease , 2019, Nature Reviews Nephrology.

[7]  C. Cardwell,et al.  Serum Biomarkers of Iron Status and Risk of Primary Liver Cancer: A Systematic Review and Meta-Analysis , 2019, Nutrition and cancer.

[8]  A. Andonova,et al.  Serum Markers of Iron Metabolism in Chronic Liver Diseases , 2018, Open access Macedonian journal of medical sciences.

[9]  Jae-Seok Hong,et al.  Impact of alcohol consumption and body mass index on mortality from nonneoplastic liver diseases, upper aerodigestive tract cancers, and alcohol use disorders in Korean older middle-aged men , 2016, Medicine.

[10]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[11]  Y. Miyagi,et al.  Regulation of iron homeostasis by the p53-ISCU pathway , 2015, Scientific Reports.

[12]  Zheng Zhang,et al.  The global burden of liver disease: The major impact of China , 2014, Hepatology.

[13]  Xifeng Wu,et al.  High serum iron is associated with increased cancer risk. , 2014, Cancer research.

[14]  L. Holmberg,et al.  Iron metabolism and risk of cancer in the Swedish AMORIS study , 2013, Cancer Causes & Control.

[15]  G. Davey Smith,et al.  Supplementary Tables , 2009 .

[16]  G. Smith,et al.  Obesity, overweight and liver disease in the Midspan prospective cohort studies , 2010, International Journal of Obesity.

[17]  C. la Vecchia,et al.  Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection. , 2009, Cancer letters.

[18]  R. Fontana,et al.  Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C. , 2006, Gastroenterology.

[19]  C. Abnet,et al.  Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China , 2005, International journal of cancer.

[20]  J. McCord.  Iron, free radicals, and oxidative injury. , 2004, Seminars in hematology.

[21]  J. Freudenheim,et al.  Serum iron, copper and zinc concentrations and risk of cancer mortality in US adults. , 2004, Annals of epidemiology.

[22]  J. Grove,et al.  Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C , 1998, Hepatology.

[23]  Z. Halpern,et al.  Elevated serum iron predicts poor response to interferon treatment in patients with chronic HCV infection , 1995, Digestive Diseases and Sciences.

[24]  J. Fraumeni,et al.  Linxian nutrition intervention trials. Design, methods, participant characteristics, and compliance. , 1993, Annals of epidemiology.

[25]  P. Taylor,et al.  Nutrition intervention trials in Linxian, China: multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia. , 1993, Journal of the National Cancer Institute.

[26]  M. Gail,et al.  Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. , 1993, Journal of the National Cancer Institute.

[27]  D. R. Kalkwarf,et al.  Iron, radiation, and cancer. , 1990, Environmental health perspectives.

[28]  C. Hann,et al.  Effect of iron and desferoxamine on cell growth and in vitro ferritin synthesis in human hepatoma cell lines , 1990, Hepatology.

[29]  G. Szabo,et al.  Alcohol and HCV: implications for liver cancer. , 2015, Advances in experimental medicine and biology.

[30]  J. Marx,et al.  Iron absorption in erythropoietin-treated haemodialysis patients: effects of iron availability, inflammation and aluminium. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[31]  K. Maier.  Iron, HCV and the liver. , 1997, World journal of gastroenterology.

[32]  S. Toyokuni,et al.  Iron-induced carcinogenesis: the role of redox regulation. , 1996, Free radical biology & medicine.